CXCR2 and neoplasm: In KRAS-driven PDAC mouse models, CAFs were shown to overexpress CXCR2 ligands promoting migration, invasion, and angiogenesis, and in fact, blocking the CXCLs-CXCR2 axis resulted in tumor cell apoptosis, decreased vessel density, and modulation of the immune infiltrate.